HRT FINANCIAL LP

Position in ANAB — Anaptysbio, Inc

CIK 1475597 NEW YORK, NY

Position in ANAB

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,246,351

-$1,153,551 QoQ

Shares Held

40,504

-42.2% QoQ

Ownership

0.139%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $416,760,191 across 198 Biotechnology names. ANAB ranks #41 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	128,633	$42,560,800
2	IBRX	ImmunityBio, Inc.	3,925,446	$30,108,170
3	EXEL	Exelixis, Inc.	460,585	$19,754,490
4	IONS	Ionis Pharmaceuticals Inc	252,250	$18,941,452
5	MRNA	Moderna, Inc.	368,421	$18,715,786
6	ARGX	Argenx SE	18,754	$13,695,108
7	RARE	Ultragenyx Pharmaceutical Inc.	613,229	$12,847,147
8	IOVA	Iovance Biotherapeutics, Inc.	3,486,299	$12,236,909

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,246,351	40,504	-42.2%	Shares	Defined	2026-05-14
2025-12-31	$3,399,902	70,130	+180.2%	Shares	Defined	2026-02-12
2025-09-30	$766,265	25,025	-42.1%	Shares	Defined	2025-11-14
2025-03-31	$803,292	43,211	+426.3%	Shares	Defined	2025-05-15
2024-09-30	$275,035	8,210	-89.1%	Shares	Defined	2024-11-12
2023-12-31	$1,620,058	75,633	+481.2%	Shares	Defined	2024-02-09
2022-12-31	$403,272	13,013	-71.7%	Shares	Defined	2023-02-10
2022-06-30	$932,419	45,932	+591.4%	Shares	Defined	2022-08-12
2021-12-31	$230,844	6,643	-79.1%	Shares	Defined	2022-02-14
2021-09-30	$860,382	31,725	-63.4%	Shares	Defined	2021-11-15
2021-06-30	$2,248,519	86,715	+281.2%	Shares	Defined	2021-08-16
2020-09-30	$335,488	22,745	+61.9%	Shares	Defined	2020-11-13
2020-06-30	$313,832	14,048	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.